Back to Search
Start Over
Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
- Source :
- Children, Vol 9, Iss 3, p 369 (2022)
- Publication Year :
- 2022
- Publisher :
- MDPI AG, 2022.
-
Abstract
- Monoclonal antibody therapies for COVID-19 have been frequently used in adults, whereas there are little data regarding the safety or efficacy of monoclonal antibody treatments in pediatric patients affected by COVID-19. We report our experience in the administration of mAb as a treatment for SARS-CoV-2 infection in children aged from 24 days to 18 years old.
- Subjects :
- COVID-19
monoclonal antibody
children
Pediatrics
RJ1-570
Subjects
Details
- Language :
- English
- ISSN :
- 22279067
- Volume :
- 9
- Issue :
- 3
- Database :
- Directory of Open Access Journals
- Journal :
- Children
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.9c0ad6bc95dc4e5ca1ff7a75728e0b9a
- Document Type :
- article
- Full Text :
- https://doi.org/10.3390/children9030369